Evolent Health Inc. has announced key additions to its leadership team. Dr. David Lim has been appointed as the chief clinical officer, where he will lead a 300-person medical team to support daily operations and innovation. John Way has joined as CFO, Performance Suite, overseeing financial aspects of at-risk specialty condition management products. These appointments aim to enhance Evolent's focus on specialty care innovation.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.